Glucagon is underused for treating severe hypoglycemia in both emergency and outpatient settings, new research suggests. Findings from an analysis of data on glucagon administration by emergency ...

For the treatment of hypoglycemia, glucagon may be underused in outpatient settings, researchers argued. In a nationwide analysis, most states only permit paramedics to carry and administer glucagon ...

GVOKE is the first premixed, prefilled, premeasured liquid glucagon offering ease of use for pediatric and adult patients with diabetes ages 2 years and above or caregivers to rapidly treat severe ...

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an ...

The first nasally administered glucagon product has been approved by the US Food and Drug Administration (FDA) to treat severe hypoglycemia. Baqsimi is first nasal glucagon product to receive US ...

Please provide your email address to receive an email when new articles are posted on . Fewer people with diabetes filled glucagon prescriptions in 2021 compared with 2011, though increases were seen ...

The US Food and Drug Administration (FDA) has approved the first nasally administered glucagon product (Baqsimi, Eli Lilly and Co) for the treatment of severe hypoglycemia for patients aged 4 years or ...

A glucagon injection kit is used to treat episodes of severe hypoglycemia , where a patient is either unable to treat themselves or treatment by mouth has not been successful. Glucagon is a hormone ...

Xeris Pharmaceuticals has taken a big step toward receiving approval for its ready-to-use formulation of glucagon in the EU. The injectable formulation, branded Ogluo, received a positive opinion from ...

Please provide your email address to receive an email when new articles are posted on . Insulin-induced hypoglycemia was effectively treated with intranasal glucagon in adults with type 1 diabetes, ...